Journal Club: Psilocybin as Treatment for Anxiety & Depression in Terminal Cancer Patients

Join Editor-in-Chief Dr. Tyler Kjorvestad, Editor-at-Large Dr. Gershom Hernandez, and Associate Editor Dr. Tony Ceman of The Journal of Psychedelic Psychiatry as they review the literature on the use of Psilocybin for the treatment of anxiety and depression in terminally ill cancer patients. 

Articles:

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.

https://www.ncbi.nlm.nih.gov/pubmed/27909164 

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.

https://www.ncbi.nlm.nih.gov/pubmed/27909165

Have an article you would like to be reviewed for potential publication or an article you would like us to discuss during the next Journal Club podcast? Send us an email at [email protected] 

Follow us:

Website: https://www.journalofpsychedelicpsychiatry.org/

Twitter: https://twitter.com/psychedelic_org

Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/

Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/

---

Support this podcast: https://podcasters.spotify.com/pod/show/journalofpsychedelic/support